Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

88
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
88
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

57
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
57
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

112
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
112
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning from sanctioned government suppliers: a machine learning and network science approach to detecting fraud and corruption in Mexico.

Scientific reports·2026
Same author

Correction: Predicting pharmaceutical prices. Advances based on purchase-level data and machine learning.

BMC public health·2024
Same author

Global Contract-level Public Procurement Dataset.

Data in brief·2024
Same author

Collusion risk in corporate networks.

Scientific reports·2024
Same author

Development aid contracts database: World Bank, Inter-American Development Bank, and EuropeAid.

Data in brief·2022
Same author

The gendered effects of foreign investment and prolonged state ownership on mortality in Hungary: an indirect demographic, retrospective cohort study.

The Lancet. Global health·2017

Related Experiment Video

Updated: Jun 21, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Predicting pharmaceutical prices. Advances based on purchase-level data and machine learning.

Mihály Fazekas1, Zdravko Veljanov2, Alexandre Borges de Oliveira3

  • 1Department of Public Policy, Central European University, Quellenstraße 51, 1100, Vienna, Austria. fazekasm@ceu.edu.

BMC Public Health
|July 15, 2024
PubMed
Summary
This summary is machine-generated.

Public health budgets face pressure to lower pharmaceutical costs. Machine learning models effectively predict drug prices using purchase data, identifying policy interventions for better value.

Keywords:
Health policyMachine learningPharmaceutical productsProcurement

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

Related Experiment Videos

Last Updated: Jun 21, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

Area of Science:

  • Health economics
  • Pharmaceutical procurement
  • Data science in healthcare

Background:

  • Rising healthcare costs strain public budgets for pharmaceutical purchases.
  • National authorities seek strategies to procure high-quality pharmaceuticals at the lowest cost.
  • Previous research often overlooked individual purchase data from public buyers.

Purpose of the Study:

  • To examine the relationship between pharmaceutical unit prices and various predictors using open public procurement data.
  • To identify the most effective models for predicting pharmaceutical unit prices.
  • To inform data-driven policy interventions for improving value for money in pharmaceutical procurement.

Main Methods:

  • Utilized over 200,000 pharmaceutical purchase records from 10 countries.
  • Analyzed data across more than 800 standardized pharmaceutical product categories.
  • Employed traditional linear regression (Ordinary Least Squares) and a random forest machine learning model.

Main Results:

  • Significant price variations for standardized pharmaceutical products were observed within and between countries.
  • The random forest model demonstrated superior performance with higher explained variance (R²=0.85) and lower prediction error (RMSE=0.81).
  • Both linear regression and random forest models showed potential for predicting unit prices.

Conclusions:

  • Large-scale purchase-level data in healthcare, combined with machine learning, can effectively explain and predict pharmaceutical prices.
  • Data-driven insights can guide policy interventions to enhance procurement efficiency and value.
  • The study highlights the potential of leveraging open procurement data for optimizing pharmaceutical spending.